美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Avalyn Pharma

28.11

+1.485.56%

盤後：28.110.00000.00%16:10 EDT

成交量：12.61萬

成交額：350.16萬

市值：11.75億

市盈率：-13.79

高：28.61

開：26.75

低：26.00

收：26.63

52周最高：32.23

52周最低：25.05

股本：4,181.20萬

流通股本：1,666.67萬

量比：0.41

換手率：0.76%

股息：- -

股息率：- -

每股收益(TTM):-2.0380

淨資產收益率：-68.34%

總資產收益率：-41.74%

市淨率：-4.92

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Avalyn Pharma

交易所：

NASDAQ

成立時間：

2010

員工人數：

50

公司地址：

105 W First Street,Boston,Massachusetts,United States

官網：

http://www.avalynpharma.com

郵編：

02127

電話：

傳真：

- -

簡介：

Avalyn Pharma Inc.於2011年5月27日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司，開發吸入藥物以治療罕見的呼吸道疾病，包括進行性肺纖維化、特發性肺纖維化和其他間質性肺部疾病。

董事

名稱

職位

Lyn Baranowski

Chief Executive Officer,Director and President

David Friedman

Independent Director

Erin Lavelle

Independent Director

Heather Turner

Board Chair and Director

Jill Carroll

Independent Director

Jon Congleton

Independent Director

Kate Haviland

Independent Director

股東

名稱

職位

Lyn Baranowski

Chief Executive Officer,Director and President

Melissa Rhodes

Chief Operating Officer

Douglas Carlson

Chief Business Officer and Chief Financial Officer

Adam Golden

General Counsel

Howard M. Lazarus

Chief Medical Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AVLN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","market":"US","secType":"STK","nameCN":"Avalyn Pharma","latestPrice":28.11,"timestamp":1779220800000,"preClose":26.63,"halted":0,"volume":126141,"hourTrading":{"tag":"盘后","latestPrice":28.11,"preClose":28.11,"latestTime":"16:10 EDT","volume":9,"amount":252.99,"timestamp":1779221404333,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0555764175741645,"floatShares":16666700,"shares":41812047,"eps":-2.038,"marketStatus":"未開盤","change":1.48,"latestTime":"05-19 16:00:00 EDT","open":26.75,"high":28.61,"low":26,"amount":3501633.1842,"amplitude":0.09801,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.038,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1779264000000},"marketStatusCode":0,"adr":0,"listingDate":1777521600000,"exchange":"NASDAQ","adjPreClose":26.63,"postHourTrading":{"tag":"盘后","latestPrice":28.11,"preClose":28.11,"latestTime":"16:10 EDT","volume":9,"amount":252.99,"timestamp":1779221404333,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.413718},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","floatShares":16666700,"roa":"-41.74%","roe":"-68.34%","lyrEps":0,"volumeRatio":0.413718,"shares":41812047,"dividePrice":0,"high":28.61,"amplitude":0.09801,"preClose":26.63,"low":26,"week52Low":25.05,"pbRate":"-4.92","week52High":32.225,"institutionHeld":0,"latestPrice":28.11,"eps":-2.038,"divideRate":0,"volume":126141,"delay":0,"ttmEps":-2.038,"open":26.75,"prevYearClose":18,"prevWeekClose":29.84,"prevMonthClose":29.49,"prevQuarterClose":18,"fiveDayClose":29.9,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVLN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVLN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVLN","date":"2026-05-18","current":-13.792934,"percent":0.25,"low":-15.129165,"twenty":-14.66101,"median":-14.471589,"eighty":-13.431244,"high":-8.833116,"avg":-13.837039,"sd":1.567162,"marketCap":1247671482},"quantilePoints":[{"date":"2026-05-01","current":-14.471589,"twenty":-13.343894,"median":-11.652352,"eighty":-9.960811,"marketCap":1233037266},{"date":"2026-05-08","current":-13.215324,"twenty":-14.430368,"median":-13.598092,"eighty":-13.264397,"marketCap":1125998425},{"date":"2026-05-15","current":-15.026112,"twenty":-14.666899,"median":-14.368536,"eighty":-13.42143,"marketCap":1280284879},{"date":"2026-05-18","current":-14.643344,"twenty":-14.66101,"median":-14.471589,"eighty":-13.431244,"marketCap":1247671482}],"updateTime":1779258009353},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":224094665,"yearFounded":2010,"employeeNum":50,"address":"105 W First Street,Boston,Massachusetts,United States","zipCode":"02127","officePhone":"(206) 707-0340","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.avalynpharma.com","stockEarnings":[{"period":"1week","weight":-0.0599},{"period":"1month","weight":0.5617},{"period":"ytd","weight":0.5617}],"compareEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0691},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.2335},{"period":"ytd","weight":0.076}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Avalyn Pharma Inc.於2011年5月27日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司，開發吸入藥物以治療罕見的呼吸道疾病，包括進行性肺纖維化、特發性肺纖維化和其他間質性肺部疾病。","exchange":"NASDAQ","name":"Avalyn Pharma","nameEN":"Avalyn Pharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":{"directors":[{"name":"Lyn Baranowski","position":"Chief Executive Officer,Director and President"},{"name":"David Friedman","position":"Independent Director"},{"name":"Erin Lavelle","position":"Independent Director"},{"name":"Heather Turner","position":"Board Chair and Director"},{"name":"Jill Carroll","position":"Independent Director"},{"name":"Jon Congleton","position":"Independent Director"},{"name":"Kate Haviland","position":"Independent Director"}],"executives":[{"name":"Lyn Baranowski","position":"Chief Executive Officer,Director and President"},{"name":"Melissa Rhodes","position":"Chief Operating Officer"},{"name":"Douglas Carlson","position":"Chief Business Officer and Chief Financial Officer"},{"name":"Adam Golden","position":"General Counsel"},{"name":"Howard M. Lazarus","position":"Chief Medical Officer"}]}}}